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OBJECTIVES The results of percutaneous mitral commissurotomy were assessed in patients with restenosis
after surgical commissurotomy.
BACKGROUND Balloon dilation is feasible in patients with restenosis after surgical commissurotomy, but little
is known about its late efficacy.
METHODS We studied 232 patients who had undergone percutaneous mitral commissurotomy a mean
of 16 6 8 years after surgical commissurotomy. Mean age was 47 6 14 years; 81 patients
(35%) had valve calcification. All patients had restenosis with bilateral commissural fusion as
assessed by echocardiography. Technical failure occurred in 9 patients and the procedure used
a single balloon in 7 patients, a double balloon in 95, and the Inoue balloon in 121.
RESULTS Complications were death in 1 patient (0.4%) and mitral regurgitation .2/4 in 10 (4%); 191
patients (82%) had good immediate results (valve area $1.5 cm2 without regurgitation .2/4).
Predictors of poor immediate results in multivariate analysis were older age (p , 0.001), lower
initial valve area (p 5 0.01) and the use of the double-balloon technique (p 5 0.015). In the
175 patients who underwent follow-up, 8-year survival without operation and in New York
Heart Association class I or II was 48 6 5%, and 58 6 6% after good immediate results. In
this latter group, poor late functional results were predicted by higher cardiothoracic index
(p , 0.0001), previous open-heart commissurotomy (p 5 0.05) and lower final valve area
(p , 0.0001) in a multivariate Cox model.
CONCLUSIONS Percutaneous mitral commissurotomy is safe and provides good immediate results in selected
patients with restenosis after surgical commissurotomy. After good immediate results, the
conditions of more than half of the patients remained improved at 8 years, enabling
reoperation to be deferred. (J Am Coll Cardiol 2000;35:1295–1302) © 2000 by the
American College of Cardiology
Mitral restenosis after surgical commissurotomy is a topic of
potential interest for percutaneous mitral commissurotomy
(PMC) because in western countries, the proportion of
recurrent mitral stenosis is increasing due to the decrease of
new cases of rheumatic valve disease. Moreover, in the case
of mitral restenosis, reoperation often consists of valve
replacement with its inherent morbidity and mortality.
Since the first report of PMC (1), its safety, immediate and
midterm efficacy have been widely demonstrated (2–5). The
feasibility of PMC has been documented in patients who
had previously undergone surgical commissurotomy, with
generally good immediate results (6–13). However, only
one series reported midterm results and showed a more
rapid deterioration at four years than in patients without
prior commissurotomy (11).
The aim of the present study is to analyze immediate and
late results of PMC for restenosis in a large single-center
series reporting a long follow-up, of up to eight years. This
enables the prediction of immediate and late results to be
analyzed, in order to improve patient selection.
METHODS
Study population. From March 1986 to June 1996, 232
patients underwent PMC for mitral restenosis after a
previous surgical commissurotomy. They had undergone a
total of 240 surgical commissurotomies: 184 patients had
had one closed-heart commissurotomy (CHC), 40 had had
one open-heart commissurotomy (OHC), and 8 had had
repeat commissurotomies (repeat CHC in 1 patient, CHC
then OHC in 7). Seven patients also had prior aortic valve
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replacement. All patients had experienced functional im-
provement following surgical commissurotomy. PMC was
performed a mean of 16 6 8 years (range, 3 to 38 years)
after surgical commissurotomy: 17 6 8 years after CHC and
11 6 5 years after OHC.
Procedure. The antegrade transvenous approach was used
in all cases. There was a failure to perform an effective
balloon dilation of the mitral valve in nine cases. Between
1986 and 1990, dilatation was performed using a single-
balloon procedure in 7 patients (Trefoil 3 3 12 mm), and
then a double-balloon procedure in 95 cases (Trefoil 3 3
10 mm or 3 3 12 mm 1 15 or 19 mm balloon) (14). The
last 121 patients underwent PMC with the Inoue balloon,
which has been systematically used since 1990, following
the stepwise technique under echo guidance (15).
Measurements. Following echocardiography and fluoros-
copy, mitral valve anatomy was classified in three anatomic
groups as previously described (3,14,16): flexible valves and
mild subvalvular disease (length of chordae $10 mm)
(group 1); flexible valves and extensive subvalvular disease
(length of chordae ,10 mm) (group 2); and calcified valves
as confirmed by fluoroscopy (group 3). In 40 patients of our
global series, the mean (6 SD) Wilkins’ score was 8.0 6 0.8
(range, 7 to 9) for anatomic group 1, 9.9 6 1.3 (range, 8 to
12) for group 2 and 12.5 6 1.3 (range, 10 to 15) for group
3 (3).
When present, valve calcification was graded from 1 to 4
according to its extent on fluoroscopic examination: 45
patients were graded 1; 25 were graded 2; 9 were graded 3;
and 2 were graded 4.
Echocardiographic examination was performed on the
day preceding PMC and 24 to 48 h after the procedure to
evaluate valve area by planimetry and Doppler pressure
half-time, mean Doppler gradient and regurgitation by
color Doppler. The reference measurement for valve area
was planimetry by two-dimensional echocardiography. In
cases of missing data, Doppler was used as substitution
measurement (3). Beginning in 1988, transesophageal echo-
cardiography was performed systematically before the pro-
cedure to eliminate left atrial thrombosis.
Before and immediately after the procedure, the degree of
mitral regurgitation was assessed according to Sellers’ clas-
sification on left ventriculography in a 30° right anterior
oblique view.
The effective balloon dilating area (EBDA) designs the
area encompassed by the circumference of the outer halves
of the two fully inflated balloons and the trapezoidal or
square area connecting their two diameters for the double-
balloon technique and the area at the last inflation for the
Inoue balloon (17).
Exclusion criteria for PMC were bicommissural or mas-
sive calcification, mitral regurgitation . grade 2, left atrial
thrombus and significant aortic valve or coronary artery
disease.
In addition, patients were selected according to the status
of the commissures as assessed by echocardiography on the
parasternal short-axis view. Patients were considered for
PMC only in the case of bilateral commissural fusion.
When one or both commissures remained opened, resteno-
sis was presumed to be mainly the consequence of a valvular
and/or subvalvular rigidity and PMC was not attempted.
End point of good immediate results. Good immediate
results of PMC were defined by a composite end point that
associates a mitral valve area $1.5 cm2 with no regurgitation
.2/4 (3,14).
Follow-up. Follow-up was performed prospectively at one-
year intervals in patients who were residing in France at the
time of their PMC and was assessed by patients’ visits to the
department or by a standardized questionnaire sent to the
patient’s cardiologist.
It was concluded in June 1997; patients were considered
unavailable for follow-up if their last follow-up examination
was before June 1996. Follow-up concerned 175 patients
and its mean duration was 46 months (range, 1 to 122); 6
patients (3%) were unavailable for follow-up.
Clinical events were combined in the following end
points:
c Survival, including all causes of mortality;
c Survival, taking into account only cardiovascular deaths;
c Survival with no need for intervention on the mitral valve
(mitral surgery or repeat PMC); and
c “Good functional results,” that is, survival with no need
for mitral surgery or repeat PMC, and in New York Heart
Association (NYHA) functional class I or II.
Statistical analysis. Quantitative variables were expressed
as mean 6 SD. For the log-rank test, logistic and Cox
models, they were divided into subgroups with clinically
chosen cutoff points. Comparison before and after PMC
used the paired Student t test. The predictive factors of
immediate results were analyzed by univariate analysis using
the unpaired Student t test for quantitative variables and the
chi-square test for qualitative variables. Univariate analysis
included the 11 preprocedure variables listed in Tables 1 and
2, the type of balloon and the EBDA. Variables with p ,
0.25 were entered in a multivariate logistic model and were
selected by a backward procedure with a threshold of p 5
0.05. The fit of the model was assessed by comparing the
predicted and observed numbers of immediate results ac-
cording to the method described by Hosmer and Lemeshow
(17a). This logistic model was then used to predict the
Abbreviations and Acronyms
CHC 5 closed-heart commissurotomy
EBDA 5 effective balloon dilating area
NYHA 5 New York Heart Association
OHC 5 open-heart commissurotomy
PMC 5 percutaneous mitral commissurotomy
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probability of good immediate results for any given patient,
according to his or her characteristics and procedure-related
variables.
Cumulative survival curves were determined according to
the Kaplan-Meier method. Univariate analysis of the pre-
dictive factors of late results was performed using a log-rank
test. The dependent variable was the previously described
composite end point “good functional results.” Independent
variables with p , 0.25 were entered in a multivariate Cox
proportional hazards model and were selected by a backward
procedure with a threshold of p 5 0.05. A predictive model
of continuing good functional results at five years was then
established using the Cox model, in which the baseline
survival function So(t) was estimated from the study popu-
lation.
All analyses was performed with statistical software (SAS
Institute Inc., release 6.11).
RESULTS
Study population. The characteristics of the 232 patients
are detailed in Table 1. These patients represent 13% of the
1,741 procedures of PMC that were performed in our
department during the same period.
Complications. The nine cases of failed procedures (4%)
were related to tamponade in one case, inability to perform
transseptal catheterization in two and to stabilize the bal-
loon across the mitral orifice in six.
There was one in-hospital death (0.4%) in a 69-year-old
woman who had previously undergone a transatrial CHC 21
years before and who had a massive tamponade immediately
after the second balloon inflation using a double-balloon
technique, suggesting a ventricular perforation. The other
severe adverse events were severe mitral regurgitation $
Sellers’ grade 3 in 10 cases (4%). Six patients experienced
transient ST-segment elevation after balloon inflation, sug-
gesting gas embolism. There was no other embolic event, in
particular no transient ischemic attack, and therefore no
embolism leaving sequelae. No patient required surgery
within the first 24 h following PMC.
Immediate results. Good immediate results as defined by
the composite end point were obtained in 191 patients
(82%). Poor immediate results were related to insufficient
valve opening (valve area ,1.5 cm2) in 22 cases (10%) and
to mitral regurgitation $ Sellers’ grade 3 in 10 (4%). The
improvement of valvular function is shown in Table 2.
The predictors of the immediate results in univariate
analysis are shown in Table 3.
The results of multivariate analysis are detailed in Table
4: the significant predictors of poor immediate results were
an older age (p , 0.0001), a lower valve area (p 5 0.01) and
the use of the single- or double-balloon procedure as
compared with the Inoue balloon (p 5 0.015). The good fit
of the multivariate model to the observed data was demon-
strated by the nonsignificant results of the Hosmer and
Lemeshow goodness-of-fit test (chi-square 5 6.81, df 5 9,
p 5 0.66). The prediction of immediate results according to
the value of the three predictors for any given patient is
shown on Table 5.
Late results. In the 175 patients who underwent follow-
up, the eight-year actuarial rates of global survival, survival
considering only cardiovascular deaths, survival with no
need for intervention and the composite end point of good
functional results were, respectively, 78 6 4%, 90 6 3%,
55 6 6%, and 48 6 5% (Fig. 1).
In the 148 patients who had had good immediate results
of PMC, the 8-year rates of global survival, survival con-
sidering only cardiovascular deaths, survival with no need
for intervention, and the composite end point of good
functional results were, respectively, 86 6 4%, 97 6 2%,
Table 1. Baseline Characteristics of the 232 Patients
Variable Mean 6 SD or n 5 (%)
Age (yr) 47 6 14
[20 to 80]
Gender
Female 196 (84)
Functional class (NYHA)
I 2 (1)
II 38 (16)
III 183 (79)
IV 9 (4)
Rhythm
Atrial fibrillation 109 (47)
Previous embolism 19 (8)
Cardiothoracic index 0.52 6 0.06
Anatomic group
1 0 (0)
2 151 (65)
3 81 (35)
Left atrial diameter (mm)
(Time-motion echocardiography)
51 6 9
NYHA 5 New York Heart Association.
Table 2. Echocardiographic Results
Variable
PMC, Mean 6 SD
or n 5 (%)
p ValueBefore After
Valve area (cm2) 1.1 6 0.2 1.8 6 0.3 , 0.0001
Mean gradient (mm Hg)
(Doppler)
9.7 6 4.4 4.9 6 2.1 , 0.0001
Mitral regurgitation
0 148 (66) 72 (32)
1 73 (33) 87 (39)
2 2 (1) 54 (24) 0.005
3 0 (0) 10 (5)
4 0 (0) 0 (0)
PMC 5 percutaneous mitral commissurotomy. The nine failed procedures are not
taken into account. Valve area was assessed by echocardiography and mitral regurgi-
tation by angiography. Mean gradient was assessed by Doppler.
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65 6 6%, and 58 6 6% (Fig. 2). Of these 148 patients, 13
died during follow-up. Three deaths were of cardiovascular
origin, related to congestive heart failure, while the other 10
were noncardiac: respiratory insufficiency in 4, neoplasia in
3, cirrhosis in 1, AIDS in 1 and suicide in 1. In 24 patients,
a subsequent intervention was required on the mitral valve.
The type of intervention was an isolated mitral valve
replacement in 13 cases, a mitral and aortic valve replace-
ment in 3, an OHC in 3 and a repeat PMC in 5. The mean
duration between PMC and the intervention was 46 months
(range, 3 to 95). All the patients who underwent a new
procedure on the mitral valve had mitral restenosis with a
mean valve area of 1.1 6 0.2 cm2 (range, 0.8 to 1.5); two
patients also had moderate mitral regurgitation and three
showed progression of an aortic valve disease. Finally, 11
patients were in NYHA class III or IV; they were waiting
for an intervention or had contraindications to surgery.
The univariate analysis of the predictors of late functional
results in the 148 patients who had had good immediate
results of PMC is shown in Table 6. The multivariate Cox
analysis identified three predictors of poor late functional
results after good immediate results of PMC (Table 7). Two
predictors were preprocedure variables, that is, a high
cardiothoracic index (p , 0.0001) and a previous OHC
(p 5 0.05). The third predictor was a lower valve area after
PMC (p , 0.0001). The prediction of good functional
results 5 years after good immediate results of PMC is
shown on Table 8.
Among the 27 patients who had had poor immediate
results of PMC, there were 8 deaths, 7 from cardiovascular
causes and 1 from extracardiac (neoplasia) causes. All the
other 19 patients underwent surgery because of insufficient
valve opening in 10 cases and mitral regurgitation $ Sellers’
grade 3 in 9. Surgery consisted of mitral valve replacement
in 18 patients and OHC in 1 patient who had poor results
from this surgery. The mean duration between PMC and
the intervention was five months (range, 1 to 26), with 13 of
Table 5. Predicted Probability of Good Immediate Results (%)
According to the Value of the Three Predictors Identified in the
Logistic Multivariate Analysis for a Given Patient
Age (yr)
Inoue Balloon Double-Balloon
<50 50–70 >70 <50 50–70 >70
Valve area (cm2)
#0.75 91 67 30 77 41 13
0.75–1.00 95 79 45 86 57 22
1.00–1.25 97 88 60 92 71 34
1.25–1.50 98 93 74 95 82 49
Table 3. Univariate Analysis of the Prediction of
Immediate Results
Variables
Results, Mean 6 SD
or %
p
ValueGood Poor
Age (yr) 45 6 12 57 6 17 0.0004
Gender
Male 91 9 0.35
Female 85 15
Functional class (NYHA)
I–II 95 5 0.06
III–IV 84 16
Previous embolism
No 87 13 0.18
Yes 75 25
Type of commissurotomy
Closed-heart 86 14 0.85
Open-heart 85 15
Duration since
commissurotomy
(yr)
15 6 8 18 6 8 0.12
Rhythm
Sinus 89 11 0.10
Atrial fibrillation 82 48
Cardiothoracic index 0.52 6 0.06 0.53 6 0.08 0.25
Anatomic group
2 91 9 0.003
3 76 24
Left atrial diameter (mm)
(Time-motion
echocardiography)
50 6 8 53 6 9 0.07
Valve area (cm2) 1.09 6 0.23 0.99 6 0.20 0.02
Mean gradient (Doppler)
(mm Hg)
9.7 6 4.4 9.9 6 4.6 0.81
Mitral regurgitation
0 88 12 0.19
1 or 2 81 19
Type of balloon
Inoue 91 9 0.02
Single or double 79 21
Effective balloon dilating
area (cm2)
5.9 6 0.7 5.7 6 0.8 0.09
Good immediate results are defined as valve area $1.5 cm2 without regurgitation
greater than Sellers’ grade 2. NYHA 5 New York Heart Association.
Table 4. Multivariate Analysis of the Prediction of
Immediate Results
Age (yrs)
(p < 0.0001) <50 50–70 >70
Odds-ratio 1 4.7 22
[2.6–8.9] [7–74]
Valve area (cm2)
(p 5 0.01) >1.25 1.25–1.00 1.00–0.75 <0.75
Odds-ratio 1 1.9 3.5 6.4
[1.2–3.0] [1.3–8.9] [1.6–26.7]
Balloon
(p 5 0.015) Inoue
Single or
Double-Balloon
Odds-ratio 1 2.9
[1.3–7.2]
Odds-ratios are related to poor immediate results (valve area ,1.5 cm2 or regurgi-
tation greater than Sellers’ grade 2) and given with their 95% confidence intervals.
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the 19 patients (68%) being operated on within the first
month following PMC.
DISCUSSION
This series further confirms the safety and immediate
efficacy of PMC for restenosis after surgical commissurot-
omy, with 82% showing good immediate results. As con-
cerns the late results, 48% of all patients were alive with no
new intervention on the mitral valve, and with few or no
symptoms at 8 years, with the corresponding figure being
58% after good immediate results. The prediction of the
results is multifactorial: it depends on the patient charac-
teristics, the technique used and the quality of the imme-
diate results.
Restenosis after surgical commissurotomy. Progressive
clinical deterioration has been shown to occur with a linear
trend in different series reporting long-term follow-up after
surgical commissurotomy (18–20). Mitral restenosis is one
of the mechanisms of deterioration after surgical commis-
surotomy, the other causes being the consequence of unsat-
isfactory results of commissurotomy, with a residual stenosis
or a severe mitral regurgitation (18,19). The incidence of
restenosis can be estimated accurately only in studies com-
prising serial assessments of mitral valve area, both early
after the procedure and during follow-up. The few studies
available reported restenosis rates of 11% for a mean
Figure 1. Cumulated rates of late events after PMC for restenosis
in the whole population who had undergone follow-up.
Figure 2. Cumulated rates of late events after PMC for restenosis
in patients who had had good immediate results (valve area $1.5
cm2 without regurgitation greater than Sellers’ grade 2).
Table 6. Univariate Analysis of the Prediction of Good Late
Functional Results in Patients Who Had Had Good Immediate
Results From PMC
Variables p Value
Before the procedure
Age 0.03
Gender 0.25
Functional class 0.13
Previous embolism 0.48
Type of commissurotomy 0.06
Duration since commissurotomy 0.13
Rhythm 0.002
Cardiothoracic index 0.0001
Anatomic group 0.06
Left atrial diameter (time-motion
echocardiography)
0.04
Mitral valve area (planimetry) 0.14
Mean transmitral gradient (Doppler) 0.78
Mitral regurgitation (Sellers) 0.38
Procedure
Type of balloon 0.05
Effective balloon dilating area 0.60
After the procedure
Mitral valve area (planimetry) 0.002
Mean transmitral gradient (Doppler) 0.14
Mitral regurgitation (Sellers) 0.43
Table 7. Multivariate Analysis of the Prediction of Late
Functional Results After Good Immediate Results
Cardiothoracic
Index
(p < 0.0001) <0.50 0.50–0.60 >0.60
Relative risk 1 3.5 12.1
[1.9–6.5] [3.5–42.2]
Type of
Commissurotomy
(p 5 0.05) Closed-Heart Open-Heart
Relative risk 1 2.2
[1.0–4.8]
Valve Area After
PMC (cm2)
(p < 0.0001) >2.00 1.75–2.00 1.50–1.75
Relative risk 1 2.6 6.6
[1.6–4.0] [2.7–16.3]
Relative risks are related to the risk of poor late functional results and are represented
with their 95% confidence intervals. PMC 5 percutaneous mitral commissurotomy.
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follow-up of 6.5 years (21) and 28% for a mean follow-up of
11 years (22).
In the present study as in the literature, the sustained
functional improvement following surgical commissurot-
omy and the duration between surgical commissurotomy
and PMC (mean of 11 to 17 years) suggested restenosis
after an initially successful procedure, rather than a residual
stenosis after surgery (6,7,10,12).
Safety of PMC. The low mortality of 0.4% in our series
compares favorably with surgery. However, it should be
stressed that the only death in our series was a tamponade,
which can occur in patients who have undergone a previous
surgical procedure despite frequent pericardial adherence
(11). Particular attention must be given to patients who
have undergone transventricular CHC, because of the
possibility of a residual apical aneurysm (10). There was no
embolism leaving sequelae; this can be related to the
systematic use of transesophageal echocardiography since
1988. Despite the frequent exclusion of left atrial appendage
after CHC, embolic risk is still present in these patients
(23). The frequency of severe traumatic mitral regurgitation
was 4% in the present series, which is close to the 3.4%
observed in our global experience of PMC (3). Series of
PMC generally do not report higher rates of severe mitral
regurgitation in patients with prior commissurotomy as
compared with first procedure (7–13).
Immediate results of PMC. The composite end point of
good immediate results used in this study associates a mitral
valve area $1.5 cm2 and no regurgitation .2/4, such
conditions generally providing normal hemodynamics
(3,14,24).
The immediate results observed in our series were good,
with 82% of patients having a valve area $1.5 cm2 and no
mitral regurgitation greater than Sellers’ grade 2. Series of
PMC for restenosis reported excellent immediate results in
young populations, with no difference when compared with
patients who did not have prior surgical intervention
(7,10,12,13). Age is a predictor of immediate results in large
series of PMC (2,3), but its predictive value is even more
marked in patients with a history of commissurotomy, as
illustrated by the value of odds-ratio in this study. This is in
accordance with our global series of PMC, in which we
found an interaction between age and previous commissur-
otomy, that is, an increase in the risk of poor immediate
results in the case of prior commissurotomy only in patients
aged .50 years (3). This explains that results were less
satisfying in series including patients with a mean age .50
years (11). As in other series of PMC, we found that valve
area before PMC was a predictor of immediate results.
The last predictor of immediate results in our series was
the technique used, with the Inoue balloon coming out
better than the double-balloon technique. The published
series of PMC for restenosis included only a few cases
performed with the Inoue balloon (10,12,13). Patients who
have a history of prior commissurotomy have more severe
impairment of valve anatomy. Our findings are consistent
with the work of Feldman et al. (25) who showed that the
impairment of valve anatomy was not a predictor of poor
results of PMC when the Inoue balloon was used. The
possibility of controlling valve opening by stepwise inflation
under echo guidance might be an explanation for the
apparent benefit of the Inoue balloon in case of impaired
valve anatomy.
Valve calcification and the duration between surgery and
PMC have been identified as predictors in other series
(7–9), but not in ours. It should be noted that valve
calcification, when present, was generally mild or moderate
in the patients of our series.
Late results of PMC. In the present series, half of the
patients who had undergone PMC for restenosis remained
alive, with no intervention on the mitral valve, and in
NYHA class I or II, 8 years after the procedure. To our
knowledge, only the article of Jang et al. (11) has so far
reported midterm results of PMC in 68 patients who had
recurrent mitral stenosis after a previous commissurotomy.
They reported a rate of survival without intervention and in
NYHA class I or II of 41% at four years, with a marked
difference according to valve anatomy, the corresponding
rates being 72% for patients with a Wilkins score #8 and
17% for a score .8. The comparison with our series must
take into account the difference in the patient characteris-
tics: patients were older, had more frequent valve calcifica-
tion and less good immediate results than in the present
series.
Table 8. Predicted Probability (%) of Good Late Functional Results Five Years After Good
Immediate Results, According to the Value of the Three Predictors Identified in Cox
Multivariate Analysis, for a Given Patient
Cardiothoracic Index
Closed-Heart Open-Heart
<0.50 0.50–0.60 >0.60 <0.50 0.50–0.60 >0.60
Valve area after PMC (cm2)
1.50–1.75 84 56 13 70 28 1
1.75–2.00 94 80 46 87 61 18
$2.00 97 92 74 94 82 51
PMC 5 percutaneous mitral commissurotomy.
1300 Iung et al. JACC Vol. 35, No. 5, 2000
PMC for Restenosis After Surgical Commissurotomy April 2000:1295–1302
The quality of the immediate results is an important
determinant of late results. The mechanism of poor late
results differs according to whether they are related to the
continuation of poor immediate results or to a secondary
deterioration following an initially successful PMC. After a
successful PMC, the major anatomic finding in the patients
who had undergone a new intervention on the mitral valve
was restenosis, either isolated or, less frequently, associated
with mitral regurgitation or with the progression of aortic
valve disease. Most patients underwent valve replacement,
but the possibility of repeating PMC in selected patients is
of interest in further deferring a surgical procedure.
In the present series, we identified three predictors of late
deterioration after good immediate results of PMC. Of the
two preprocedure related predictors, the most significant
was cardiothoracic index. Cardiomegaly is a marker of the
advanced stage of heart disease and it was a predictor of late
outcome in a large series of CHC (20).
Another predictor of late deterioration after PMC for
restenosis was the type of the initial commissurotomy. The
risk of late deterioration was higher after OHC, as com-
pared with CHC. A possible explanation is that the patients
in our series who had initially undergone OHC generally
had more severe valve disease than in the case of CHC.
Other series of PMC for restenosis included only a few
patients who had had OHC and did not specifically study
those patients (7,10,12).
Mitral valve area after PMC has been shown to be
predictive of late results after PMC in series including all
procedures, regardless of the immediate results (4,5). Even
when considering patients who had had good immediate
results from PMC, valve area after the procedure remains a
predictor of late outcome after PMC for restenosis.
Valve anatomy was not a predictor of late outcome in the
present series, whereas it was singled out as the major
determinant of late outcome in the only other series report-
ing midterm follow-up after PMC for recurrent mitral
stenosis (11). In the particular field of recurrent mitral
stenosis, we chose to select patients according to the
echocardiographic analysis of commissural status in addition
to the global evaluation of valve anatomy. Anatomic studies
have shown that mitral restenosis after surgical commissur-
otomy may be associated with recurrent fusion of the
commissures, but also to rigidity of the leaflets and/or the
subvalvular apparatus, with commissural opening persisting
from the first commissurotomy (26,27). The latter cases are
obviously not suitable for an iterative commissurotomy (27).
Besides the aforementioned differences between the popu-
lations involved, the scoring system used to assess valve
anatomy differs between different series. Apart from the
usual exclusion criteria, the selection of patients who had
fusion of both commissures in the present series may have
led to the exclusion of the patients with the most severe
impairment of valve anatomy. However, it should be noted
that no patient had ideal anatomic conditions (anatomic
group 1). Therefore, the lack of patients with ideal anatomy,
together with the small number of patients with severe valve
impairment, probably narrowed the spectrum of anatomic
presentations encountered in the present series and there-
fore limited the importance of valve anatomy in the predic-
tive analysis.
Surgery for mitral restenosis. The severity of the valve
disease observed in many patients with mitral restenosis and
the desire to avoid a third intervention explains why mitral
valve replacement is frequently performed in those patients
(28,29). This reoperation carries an inherent risk of opera-
tive mortality and also prosthetic-related complications.
The feasibility of a repeat commissurotomy in case of
restenosis was demonstrated when the only treatment of
mitral stenosis was CHC. Morbidity and mortality were
higher than for the first operation, but repeated commis-
surotomy could lead to further clinical improvement, in
particular in young patients with noncalcified valves (30).
Repeated CHC is still considered as a treatment of choice
for restenosis in developing countries, in particular for
economic reasons (23).
Good late functional results are obtained with OHC, but
no series has specifically studied its results in case of restenosis,
and its superiority over CHC is controversial (29,31). When
performed for restenosis, OHC has the disadvantage of po-
tentially leading to a third intervention for most patients.
Clinical implications. The present findings demonstrate
the safety and immediate efficacy of PMC in a wide range of
patients with restenosis after surgical commissurotomy who
were selected, in particular, on the basis of bilateral com-
missural fusion as assessed by echocardiography. After poor
immediate results, valve replacement is generally required at
short-term. In contrast, after good immediate results, PMC
enables reintervention to be deferred for at least 8 years in
more than half of the patients.
In addition, the analysis of the results shows that their
prediction is intrinsically multifactorial and it therefore
provides useful information in optimizing patient selection.
The possibility of deferring surgery for many years is of
particular importance in young patients without advanced
heart disease, for whom no surgical alternative is totally
satisfying. However, in older patients whose heart disease is
at an advanced stage and in whom other characteristics
predict a probable very poor outcome, surgical therapy can
be considered as the first alternative in the absence of
contraindications.
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